Status:
COMPLETED
Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose.
Lead Sponsor:
Ziekenhuis Oost-Limburg
Conditions:
Critically Ill
Acute Kidney Injury
Eligibility:
All Genders
Phase:
NA
Brief Summary
Rationale: A higher citrate dose during continuous venovenous hemofiltration provides better anticoagulation but possibly a higher risk of citrate accumulation in case of metabolic limitations. A hig...
Eligibility Criteria
Inclusion
- Critically ill patients requiring CRRT for AKI (RIFLE criteria)
- Written informed consent from the patient or legal representative
Exclusion
- pre-existing chronic renal insufficiency requiring dialysis
- chronic immunosuppression
- liver cirrhosis Child-Pugh C
- severe or shock-related hepatitis
- Pregnancy
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT02194569
Start Date
July 1 2014
End Date
June 1 2017
Last Update
April 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost Limburg
Genk, Limburg, Belgium, 3600